Dermatologicals

Retail sales of dermatological products in Thailand experienced accelerated growth in current value terms in 2023, following the return of consumers to more active lifestyles outside the home. With this increased mobility came a greater risk of…

Dermatologicals is set to maintain a healthy growth trajectory in current value terms in Brazil in 2023, in line with the increase recorded in 2022, driven mainly by price rises. The pandemic years were marked by a reduction in Brazilians’ purchasing…

Skin diseases across all age groups continues to drive growth for dermatologicals. Skin diseases are common in rural areas due to poor hygiene and in urban areas due to overcrowded neighbourhoods, with many having no access to proper sanitary…

While overall consumer awareness of skin diseases and infections is increasing in Kenya, there remain areas where stigma persists, creating a reluctance among consumers to seek help. For instance, vaginal antifungals are linked to the stigma of…

Climatic and social conditions drive the sale of paediatric dermatologicals products in Nigeria. As well as being more sensitive to environmental factors than adults, children’s lifestyles expose them to conditions that lead to skin problems,…

Dermatologicals in Hong Kong saw continued positive growth in 2023. Steady growth in antifungals was driven by medicated shampoos, vaginal antifungals and other dermatologicals such as topical allergy remedies/antihistamines, with hair loss…

In 2023, dermatologicals is set to return to solid current value growth, although performances are expected to vary widely across categories. For instance, hair loss treatments is expected to continue to benefit from consumers’ perception of their…

Sales of dermatologicals have benefited from the return to normal activities following the lifting of pandemic-related restrictions. Consumers are out in public again and socialising and are consequently looking to treat any conditions to ensure thy…

Dermatologicals has performed impressively in 2023, with all categories set to record stronger volume growth rates than in 2022. Demand for some product types has picked up as the increased levels of social contact brought about by the easing of the…

Dermatologicals is seeing steady single-digit growth in current value terms in 2023. Two of the most important product areas, topical antifungals and vaginal antifungals, are both seeing moderate growth in 2023, although this is largely due to…

Dermatologicals is projected to continue to see positive, if slow, retail value (constant 2023 prices) growth in 2023. However, after posting robust retail volume gains in 2021 and 2022, most categories are projected to see declines in retail volume…

Retail sales of dermatologicals saw a second year of healthy growth in constant value terms in 2023. The category suffered a decline during the pandemic, when consumers spent more time at home and were therefore less exposed to environments which…

Dermatologicals continues its positive development in 2023, although value growth has subsided slightly compared to 2022 levels. On balance, value sales are still stronger than the pre-pandemic era when demand dropped amid social distancing and home…

As is the case across consumer health in Taiwan, herbal/traditional varieties have continued to gain popularity in dermatologicals in 2023 amidst rising awareness of the potentially harmful side effects and contraindications of active pharmaceutical…

Dermatologicals has seen a return to growth in current value terms in 2023, which is mainly due to the waning impact of COVID-19 on consumer lifestyles and behaviours. Antipruritics is one of the largest categories within dermatologicals and has also…

Skin diseases across all age groups continues to drive growth for dermatologicals. Skin diseases are common in rural areas due to poor hygiene and in urban areas due to overcrowded neighbourhoods, with many having no access to proper sanitary…

Dermatologicals in Azerbaijan is recording an upward trajectory in 2023 but at a pace that could generously be called moderate, and notably slower in terms of volume sales compared to 2022. When it comes to dermatologicals, local consumer education…

International players with broad portfolios continue to lead the way in dermatologicals, with Bayer Romania the top-ranked company. Bayer Romania’s Canesten, the best-selling product in both topical and vaginal antifungals, is expected to maintain…

Affordability is a key factor within dermatologicals, with some products on the landscape being very expensive for the average consumer. As such, people need to find products within their budget, allowing them to address their specific skin issues.…

With society operating normally once again, after the pandemic, visits to doctors in relation to skin conditions have increased. This is seeing products such as topical antifungals, vaginal antifungals, cold sore treatments, and haemorrhoid…